Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Itopride | Drug | |||
| Placebo | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| 24-hour pH Monitoring | after 5 days of treatment |
Not provided
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Philip, Jr. B. Miner, M.D. | The Oklahoma Foundation for Digestive Research | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Oklahoma Foundation for Digestive Research | Oklahoma City | Oklahoma | 73104 | United States |
Not provided
| ID | Term |
|---|---|
| D006356 | Heartburn |
| ID | Term |
|---|---|
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| C102254 | itopride |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided